FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for eplerenone filed by Mylan Pharmaceuticals Inc. This action updates regulatory aspects of the drug, such as label…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Hypertension

Drugs mentioned

• eplerenone (eplerenone)

Snippet

SUPPL AP for EPLERENONE (EPLERENONE)